BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  PrescribeWellness Partners With Venebio to Help Local Pharmacies Address the Opioid Epidemic

  PrescribeWellness announced that it has partnered with life sciences research consultancy Venebio Group to leverage the company’s new prescription opioid risk assessment tool, Venebio Opioid Advisor™ (VOA).

  March 8, 2018

   · 

  2 min read
• Business

  Evotec and Sanofi in Exclusive Talks to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform

  Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near Lyon, France.

  March 8, 2018

   · 

  4 min read
• Pharm Country

  Next Generation Biologics, Janssen’s Tremfya, Eli Lilly’s Taltz, and Novartis’ Cosentyx, Raising the Bar in Psoriasis Management

  A recent study published by Spherix Global Insights reveals that the newest psoriasis entrant, Tremfya, has made substantial gains in penetrating first-line biologic therapy for psoriasis.

  March 8, 2018

   · 

  4 min read
• Business

  Nobilis Health Reports Fourth Quarter and Full Year 2017 Financial Results

  Full year total revenue of $299.7 million, a 4.9% increase over prior year

  March 8, 2018

   · 

  26 min read
• Genetown

  Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases

  Financing proceeds will be used to advance RAD51 inhibitor toward the clinic and expand small-molecule synthetic lethality platform for oncology and autoimmune diseases.

  March 8, 2018

   · 

  5 min read
• Portage invests in iOx Therapeutics, an United Kingdom-based cancer immunotherapy company

  Portage will invest US$950,000 by subscribing to an unsecured, one-year convertible loan instrument.

  March 8, 2018

   · 

  5 min read
• Pharm Country

  Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with Parkinson’s and Other Neurodegenerative Diseases

  Investors in the round included OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners L.P., Boxer Capital, LLC, Adage Capital Management L.P., and Alexandria Venture Investments.

  March 8, 2018

   · 

  4 min read
• Pharm Country

  Onkos Surgical® Announces Major Milestone with First Patient Entered in the Surgical Oncology Research Team (SORT™) Registry

  The SORT Registry, sponsored by Onkos Surgical, is the first of its kind, multicenter, platform designed to prospectively collect functional, psychosocial and oncological outcomes.

  March 8, 2018

   · 

  3 min read
• Cytox Awarded New Innovate UK Funding for Alzheimer’s Testing

  Cytox is pleased to announce that, in partnership with Cardiff University, the company has been awarded funding by Innovate UK.

  March 8, 2018

   · 

  1 min read
• Business

  Tocagen Reports Fourth Quarter and Full Year 2017 Financial and Business Results

  Tocagen Inc. reported financial results and business highlights for the fourth quarter and full year ended December 31, 2017.

  March 8, 2018

   · 

  5 min read